Открытое Акционерное Общество "Татхимфармпрепараты" (RU)
发明人:
Ханнанов Тимур Шамилович (RU),Анисимов Александр Николаевич (RU),Шильникова Ольга Александровна (RU),Степанова Наталья Владимировна (RU),Газизова Наиля Ганиевна (RU),Хамидуллин Рустем Тафкилевич (RU)
申请号：
RU2012148461/15
公开号：
RU2012148461A
申请日:
2012.11.14
申请国别(地区):
RU
年份:
2014
代理人:
摘要：
1. A medicament for the treatment of cataract based on active substance digidroazapentatsena sodium polysulfonates (azapentatsena), characterized in that it is in the form of eye drops, ointment or gel and azapentatsena dosage is 0,0050-0,0300 wt.% Vklyuchitelno.2. A medicament according to claim 1, characterized in that it is in the form of eye kapel.3. A medicament according to claim 1, characterized in that it is in the form mazi.4. A medicament according to claim 1, characterized in that it is in the form gelya.5. A medicament according to claim 2, characterized in that to stabilize and izotonirovaniya using borate buffer and potassium chloride at the following ratio, wt.%: 6. A medicament according to claim 2, characterized in that to stabilize and izotonirovaniya using borate buffer and sodium chloride in the following ratios, mass.%: 7. A medicament according to claim 2, characterized in that for stabilizing the phosphate buffer used in the following ratios, mass.%: 8. A medicament according to claim 2, characterized in that sodium is used as a pH regulator hloristovodorodnaya.9 hydroxide or acid. A medicament according to claim 2, characterized in that quaternary ammonium is used as a preservative (benzalkonium chloride, tsetilmetilammony bromide, cetylpyridinium chloride, benzethonium chloride, etc.) in an amount of 0.0001 - 0.015 wt% 10... A medicament according to claim 2, characterized in that the mixture is used as preservatives and preservative parabens esters from the group of mercury, wt.%: Preferably: from gruppy11 preservative. A medicament according to claim 2, characterized in that as preservative1. Лекарственное средство для лечения катаракты на основе действующего вещества дигидроазапентацена полисульфоната натрия (азапентацена), отличающееся тем, что выполнено в виде глазных капель, мази или геля и дозировка азапентацена составляет 0,0050-0,0300 мас.% включительно.2. Лекарственное средство по п.1, отличающееся тем, что выполнено в виде глазных
